Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 26, 2007. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding a specific executive transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction involving Dr. R. G. Greig:
- Event: Vesting of 4,509.44 Ordinary Share ADRs under the GlaxoSmithKline Deferred Investment Award.
- Date of Vesting: February 1, 2007.
- Payment Date: February 23, 2007.
- Value: Payment equivalent to GBP 54.92 per ADR.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the disclosed executive transaction.
Key Facts for Investor Verification
- Verify the total value of the transaction (4,509.44 ADRs x GBP 54.92).
- Confirm the current shareholding balance of Dr. R. G. Greig following this vesting event.
- Review the terms of the GlaxoSmithKline Deferred Investment Award to understand future vesting schedules.